CENTA Stock Analysis: Central Garden & Pet | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 2.449m USD | 12M Return: 38.4% | US1535272058 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 11.7M
EPS Trend: 89.1%
Qual. Beats: 0
Rev. Trend: -92.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Central Garden & Pet Company (NASDAQ: CENTA) is a U.S. consumer products company that manufactures and distributes branded goods across two segments: Pet and Garden. The Pet segment supplies dog and cat products, aquatics, small animal and reptile care, bird, equine, and livestock items, while the Garden segment offers grass and packet seed, wild bird feed, fertilizers, live plants, and pest control products.
The company runs a multi-brand portfolio-selling under names such as Aqueon, Cadet, Farnam, Kaytee, Nylabone, Pennington, and Sevin-and distributes through independent distributors, big-box retailers, national and regional chains, e-commerce platforms, grocery stores, nurseries, and mass merchants. Founded in 1955 and headquartered in Walnut Creek, California, Central Garden & Pet operates within the Consumer Staples sector (Household Products), a defensive category whose demand for pet care and basic lawn/garden maintenance tends to be relatively stable through economic cycles.
- Pet category premiumization drives higher-margin product mix
- Garden segment revenue volatile amid weather and seasonality
- Raw material inflation pressures consolidated gross margins
| Net Income: 166.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 0.58 > 1.0 |
| NWC/Revenue: 50.94% < 20% (prev 46.09%; Δ 4.85% < -1%) |
| CFO/TA 0.10 > 3% & CFO 390.3m > Net Income 166.3m |
| Net Debt (627.4m) to EBITDA (348.7m): 1.80 < 3 |
| Current Ratio: 3.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (61.9m) vs 12m ago -3.63% < -2% |
| Gross Margin: 32.54% > 18% (prev 31.08%; Δ 1.46% > 0.5%) |
| Asset Turnover: 82.82% > 50% (prev 85.32%; Δ -2.49% > 0%) |
| Interest Coverage Ratio: 4.66 > 6 (EBIT TTM 266.9m / Interest Expense TTM 57.2m) |
| A: 0.41 (Total Current Assets 2.13b - Total Current Liabilities 563.7m) / Total Assets 3.79b |
| B: 0.31 (Retained Earnings 1.18b / Total Assets 3.79b) |
| C: 0.07 (EBIT TTM 266.9m / Avg Total Assets 3.72b) |
| D: 0.85 (Book Value of Equity 1.75b / Total Liabilities 2.04b) |
| Altman-Z'' = 5.11 = AAA |
| DSRI: 0.89 (Receivables 460.2m/522.7m, Revenue 3.08b/3.12b) |
| GMI: 0.95 (GM 31.08% / 32.54%) |
| AQI: 1.01 (AQ_t 0.29 / AQ_t-1 0.29) |
| SGI: 0.99 (Revenue 3.08b / 3.12b) |
| TATA: -0.06 (NI 166.3m - CFO 390.3m) / TA 3.79b) |
| Beneish M = -3.17 (Cap -4..+1) = AA |
As of November 02, 2026, the stock is trading at USD 39.12 with a total of 457,886 shares traded. Over the past week, the price has changed by +0.05%, over one month by +15.23%, over three months by +2.73% and over the past year by +38.38%.
Current recommended Stop Loss: 38.00 (which is 2.9% or 1.2 ATR below the current price).
Central Garden & Pet has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy CENTA.
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 46.3 | 18.2% |
P/E Trailing = 14.4926
P/E Forward = 12.0773
P/S = 0.7942
P/B = 1.4023
P/EG = 1.866
Revenue TTM = 3.08b USD
EBIT TTM = 266.9m USD
EBITDA TTM = 348.7m USD
Long Term Debt = 1.19b USD (from longTermDebt, last quarter)
Short Term Debt = 50.7m USD (from shortTermDebt, last quarter)
Debt = 1.62b USD (from shortLongTermDebtTotal, last quarter) + Leases 215.5m
Net Debt = 627.4m USD (calculated: Debt 1.62b - CCE 996.7m)
Enterprise Value = 3.08b USD (2.45b + Debt 1.62b - CCE 996.7m)
Interest Coverage Ratio = 4.66 (Ebit TTM 266.9m / Interest Expense TTM 57.2m)
EV/FCF = 8.90x (Enterprise Value 3.08b / FCF TTM 345.6m)
FCF Yield = 11.23% (FCF TTM 345.6m / Enterprise Value 3.08b)
FCF Margin = 11.21% (FCF TTM 345.6m / Revenue TTM 3.08b)
Net Margin = 5.39% (Net Income TTM 166.3m / Revenue TTM 3.08b)
Gross Margin = 32.54% ((Revenue TTM 3.08b - Cost of Revenue TTM 2.08b) / Revenue TTM)
Gross Margin QoQ = 35.92% (prev 33.06%)
Tobins Q-Ratio = 0.81 (Enterprise Value 3.08b / Total Assets 3.79b)
Interest Expense / Debt = 3.52% (Interest Expense 57.2m / Debt 1.62b)
Taxrate = 24.15% (52.9m / 219.2m)
NOPAT = 202.4m (EBIT 266.9m * (1 - 24.15%))
Current Ratio = 3.79 (Total Current Assets 2.13b / Total Current Liabilities 563.7m)
Debt / Equity = 0.93 (Debt 1.62b / totalStockholderEquity, last quarter 1.75b)
Debt / EBITDA = 1.80 (Net Debt 627.4m / EBITDA 348.7m)
Debt / FCF = 1.82 (Net Debt 627.4m / FCF TTM 345.6m)
Total Stockholder Equity = 1.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.47% (Net Income 166.3m / Total Assets 3.79b)
RoE = 10.15% (Net Income TTM 166.3m / Total Stockholder Equity 1.64b)
RoCE = 9.42% (EBIT 266.9m / Capital Employed (Equity 1.64b + L.T.Debt 1.19b))
RoIC = 6.48% (NOPAT 202.4m / Invested Capital 3.12b)
WACC = 4.46% (E(2.45b)/V(4.07b) * Re(5.64%) + D(1.62b)/V(4.07b) * Rd(3.52%) * (1-Tc(0.24)))
Discount Rate = 5.64% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.65 | Cagr: -3.32%
[DCF] Terminal Value 76.74% ; FCFF base≈332.3m ; Y1≈363.1m ; Y5≈455.6m
[DCF] Fair Price = 123.5 (EV 6.97b - Net Debt 627.4m = Equity 6.34b / Shares 51.3m; r=8.35% [WACC [floored]]; 5y FCF grow 10.69% → 2.50% )
EPS Correlation: 89.10 | EPS CAGR: 12.58% | SUE: 0.47 | # QB: 0
Revenue Correlation: -92.87 | Revenue CAGR: -2.78% | SUE: -0.27 | # QB: 0
EPS current Quarter (2026-12-31): EPS=0.12 | Chg30d=-38.46% | Revisions=-25% | Analysts=1
EPS current Year (2026-09-30): EPS=2.97 | Chg30d=+0.00% | Revisions=+17% | GrowthEPS=+8.9% | GrowthRev=-3.7%
EPS next Year (2027-09-30): EPS=3.09 | Chg30d=+1.09% | Revisions=+29% | GrowthEPS=+3.9% | GrowthRev=+1.2%
[Analyst] Revisions Ratio: +18% (up=5, down=3)